Lobbying by Canadian Health Coalition: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.
In-house (organization)In effect since Feb 27, 2026
Filed by Steven Staples, National Director of Policy and Advocacy
Lobbyists
Steven Staples · National Director of Policy and Advocacy
Institutions they may lobby: Health Canada (HC), House of Commons, Patented Medicine Prices Review Board (PMPRB), Prime Minister's Office (PMO), Privy Council Office (PCO), Senate of Canada
What they're lobbying on (4)Hide details
The CHC supports the establishment of a national pharamcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).
The CHC supports the establishment of national standards for long term care, supported through conditional federal financial funding.
The CHC supports the Canada Health Act and the enforcement of its provisions by the federal government using its spending authority.
The CHC support Canada's voluntary-collection system for blood and blood products, including plasma. It opposes the paid-collection of blood and blood products.
Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
Justine Frame · Policy Advisor, Health Canada (HC)
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
The CHC supports the Canada Health Act and the enforcement of its provisions by the federal government using its spending authority.Read more
The CHC supports the establishment of a national pharamcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).
Adam Moore · Legislative assistant, House of Commons
The CHC support Canada's voluntary-collection system for blood and blood products, including plasma. It opposes the paid-collection of blood and blood products.Read more
The CHC supports the Canada Health Act and the enforcement of its provisions by the federal government using its spending authority.
The CHC supports the establishment of a national pharamcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).
Justine Frame · Policy Advisor, Health Canada (HC)
Roy Karam · Advisor, Economic and Health System Policy, Health Canada (HC)
The CHC supports the establishment of a national pharmcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).Read more
Claudia Gallant · Stakeholder Relations Advisor, House of Commons
Luhan Yao · Policy Officer, House of Commons
The CHC supports the establishment of a national pharmcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).Read more
The CHC supports the Canada Health Act and the enforcement of its provisions by the federal government using its spending authority.
Yeba Sandenga · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Justine Frame · Special Assistant- Policy, Health Canada (HC)
The CHC supports the establishment of a national pharmcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).Read more
The CHC supports the establishment of a national pharmcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).Read more
The CHC supports the establishment of a national pharmcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).Read more
The CHC supports the establishment of a national pharmcare program, based on the recommendations contained in the Final Report of the Advisory Council on the Implementation of National Pharmacare (2019).Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.